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a b s t r a c t
Objectives: Concurrent intraductal papillary-mucinous neoplasm (IPMN) and autoimmune pancreatitis
(AIP) was observed in a patient (index case) at our institution. Cases of coincidental IPMN and type 1 AIP
and concurrent ductal adenocarcinoma (PDAC) and AIP have been previously reported. In this study we
evaluate the hypothesis that IPMN elicits an IgG4 response.
Methods: Twenty-one pancreases (including the index case) with IPMN resected at our institution were
studied. H&E stained slides were reviewed and blocks of peritumoral pancreas were immunostained
with IgG4 to look for IgG4-positive plasma cells.
Results: We found evidence of variable IgG4 overexpression in 4/21 (19%) of IPMN. These included the
index case and three others without stigmata of AIP.
Conclusion: A small subset of pancreatic neoplasms including intraductal papillary-mucinous neoplasms
(IPMN) is associated with an IgG4 autoimmune response that sometimes progresses to peritumoral type
1 AIP and less often to diffuse AIP and IgG4-related systemic disease.
© 2017 IAP and EPC. Published by Elsevier B.V. All rights reserved.
1. Introduction
In 2011, we diagnosed a pancreas resected at DHMC as having
both an intraductal papillary mucinous neoplasm (IPMN) and
autoimmune pancreatitis (AIP). The AIP was localized around the
IPMN and did not involve pancreas remote from the IPMN. This
localization raised two questions: (1) is this situation reflective of
an association between the diseases, or (2) is an autoimmune
response to the IPMN causing or being misinterpreted as AIP.
Beginning in 2013, reports of seven cases of IPMN associated with
AIP were published from other centers [1e5]. Tabata et al.
concluded “the association of an IPMNwith AIP type 1-like changes
seems to be exceptional and coincidental.” [4] Whereas Vaquero
et al. concluded that “Common risk factors to IPMN and AIP may
facilitate its coincidental generation.” [5].
In one of the published cases, imaging studies documented the
presence of cysts (presumably IPMN) for 3 years before changes of
AIP were noted [2]. In five cases, the AIP was type 1, a form of AIP
that is associated with elevation of serum IgG4 and infiltrates of
IgG4 positive plasma cells in involved tissues. Separately, it had
been reported that pancreatic ductal adenocarcinomas without AIP
were sometimes found to have peritumoral infiltrates with con-
spicuous IgG4-positive plasma cells when there were no other
stigmata of AIP [6]. However, the counts of IgG4-positive cells were
lower in the peritumoral infiltrates than in type 1 AIP. These ob-
servations suggest the possibility (hypothesis) that some pancreatic
neoplasms including IPMN elaborate an antigenic epitope that
elicits an IgG4 response. The current project is undertaken to
evaluate the relationship between an autoimmune IgG4 response,
IPMN and AIP. One possible outcome is that peritumoral AIP is a
new and previously unrecognized subset of type 1 AIP. In our pa-
tient and in two of the previously reported cases there is evidence
supporting a diagnosis of IgG4-related systemic disease. This raises
the additional question of whether a tumor associated-IgG4
response may sometimes progress to systemic IgG4-related dis-
ease with AIP.
2. Materials and methods
We systematically searched the Dartmouth-Hitchcock Medical
Center (DHMC) pathology database for diagnoses of IPMN between
2000 and 2014, and 21 surgical pathology specimens (including the
index case) were retrieved from the files of DHMC. Our series was
consecutive except that it was necessary to eliminate 36 cases
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because they were referred (outside) cases and we did not have the
blocks in our files. Slides from these cases were reviewed to choose
areas of the IPMN wall with well preserved epithelial lining and
adjacent stroma with a leukocytic infiltrate if this was present. We
searched for ductal or stromal changes with stigmata of autoim-
mune pancreatitis but found none in either the tumor wall or the
remote pancreas except in the index case. One and sometimes two
blocks of tumor wall were chosen from each case for immuno-
staining with antibody to IgG4.
Entire sections immunostained using anti-IgG4 antibody were
scanned at 40X magnification using a Leica SNC 400 scanner.
Counts of IgG4-positive plasma cells were made independently by
two observers (AH and DSL) using printouts of 450,886 mm2 fields.
The average of the three highest counts is reported and was used
for calculations. In the event that it was difficult to find fields with
more than 2 positive cells, we photographed 1 or 2 fields and
counted additional fields online.
3. Results
Although the response is variable and graded, 4/21 IPMN (19%)
showed infiltrates of IgG4-positive plasma cells (Fig. 1) that are
clearly above background levels [7] (Table 1). Cases were re-graded
based on the revised classification system and recommendations
from the Baltimore consensus meeting for neoplastic precursor
lesions in the pancreas [8]. These included the index case (Case 9).
Additional detail is provided for our index case because of its
importance in stimulating our study. The index case was a 53-year-
old man, with past medical history significant for allergy and
depression, who presented to an outside hospital with severe
bloody diarrhea after a foreign trip. Infectious etiology work-up
was negative. Symptoms temporarily subsided but did not resolve
completely. Further work-up continued at DHMC, where a CAT scan
of the abdomen showed a pancreatic cyst measuring 4.5 cm in
diameter with a thick wall in the tail of the pancreas and a splenic
artery aneurysm measuring 1.2 cm. No mural nodules, septations,
calcifications or adenopathy were noted in the imaging studies.
Diagnosis of cystadenoma or cystadenocarcinoma was suggested.
No history of trauma to the abdomen, pancreatitis, or weight loss,
was reported.
Preoperative endoscopic ultrasound showed a 3.3 cm thick-
walled single-compartment cyst without septae in the pancreatic
tail. The outer wall of the lesion was asymmetrically thick
measuring up to 9 mm. Fine needle aspiration was significant for
5 ml of clear and viscous fluid. Fluid amylase and CEA were mark-
edly elevated (amylase: >5250 unit/L; CEA: 297.9 ng/ml). Cytology
showed clusters and strips of generally bland ductal epithelial cells,
stroma and connective tissue with chronic inflammatory cells,
fibrosis, a small amount of mucin, and abundant debris. These
findings were suspicious for a cystic mucinous neoplasm. The pa-
tient underwent open distal subtotal pancreatectomy with en-bloc
splenectomy, mobilization of the splenic flexure, and retroperito-
neal exploration for metastasis.
Macroscopically, the resection specimen showed a 3.1 cm oli-
golocular cyst with fibrous septae, containing mucoid fluid and a
0.5  0.4 x 0.3-cm, pink, fleshy excrescence within the cyst wall.
The spleen was grossly unremarkable.
Fig. 1. A) low power H&E, 200X, demonstrates epithelial lining with increased lym-
phoplasmacytic infiltration in the wall of the IPMN. B), IgG4 immunostaining, 200X,
highlights the IgG4 positive plasma cells. This area was not part of a “hot spot”.
Table 1
Cases indicating number of IGg4-positive cells and grading.
Case Number Average count Avg count per HPFa Grade
1 7.5 3.7 Low grade
2 0.33 0.2 Low grade
3 1.33 0.7 Low grade
4 0 0 Low grade
5 13.33 6.6 High grade
6 0 0 Low grade
7 0.33 0 Low grade
8 40.67 20.1 High grade
9ab 72 35.6 Low grade
9b 118.33 216.5 Low grade
9c 66.57 33 Low grade
10 13.67 6.8 High grade
11 31.33 15.5 High grade
12 11.33 5.6 High grade
13 2.5 1.2 High grade
14 0.67 0.3 Low grade
15 4.5 2.2 High grade
16 19.33 9.6 High grade
17 191.67 94.9 Low grade
18 3.67 1.8 Low grade
19 3.17 1.6 Low grade
20 0 0 Low grade
21 1 0.5 Low grade
a This is a calculated count per 40X field. The area of the rectangular field we used
for counting IgG4-positive cells is about twice that of an average circular 40X high
power field that we calculate to be 223,100 mm2.
b Serum IgG and IgG4 level were elevated in this patient as noted below. Serum
IgG level was also determined in patients 6 and 7 and was 530 and 531 mg/dL
respectively (normal range 7e89 mg/dL) Immunoglobulin levels were not deter-
mined in other patients.
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Histologically, the cysts were lined by tall columnar cells with
eosinophilic cytoplasm, abundant intracellular and extracellular
mucin and basally located nuclei resembling gastric foveolar-type
epithelium. The main pancreatic duct was not involved. Stroma
was paucicellular with no evidence of invasion. Thirty-four lymph
nodes were free of malignancy. The diagnosis was low grade,
branch duct-type intraductal papillary mucinous neoplasm.
One year later a lymph node excision was performed at an
outside institution and showed reactive lymphoid hyperplasia with
progressive transformation of germinal center and markedly
increased IgG4 positive cells in the germinal centers (>100/HPF and
IgG4/IgG >40%). Serum IgG was 1276 mg/dL (normal range
791e1643) and serum IgG4 was 275 mg/dL (normal range
7e89 mg/dL). Serum IgM, IgA, CBC, CRP, viral, ANA, ANCA, anti-
centromere antibody and rheumatoid factor were within normal
range. The lymph node findings were consistent with IgG4-related
lymphadenopathy, type IV.
Pathologic review of the previously performed subtotal-
pancreatectomy revealed fibrosis with focal storiform pattern and
periductal lymphoplasmacytic inflammation with frequent eosin-
ophils and multiple reactive lymphoid follicles. A medium-sized
artery revealed focal vasculitis with fibrosis, abundant lympho-
plasmacytic cells, and lymphoid follicle formation. Immunohisto-
chemistry for CD138 and IgG showed increased plasma cells in
multiple areas. IgG4 showed >50 cells/HPF in >3 areas with an
IgG4/IgG ratio >40%. The final histopathologic diagnosis was IgG4-
related autoimmune pancreatitis, in addition to low-grade intra-
ductal papillary mucinous neoplasm.
4. Discussion
Table 2 lists five reports that include seven patients with peri-
tumoral AIP associated with IPMN. Naitoh et al. noted that detec-
tion of the pancreatitis and cyst was coincidental in a patient with a
normal serum IgG4 level [1]. Bateman et al. reported two cases with
AIP that both showed stigmata of IgG4-related systemic disease,
but concluded that most chronic pancreatitis associated with IPMN
is not AIP [3]. Urata et al. reported that cystic masses preceded AIP
by three years in their patient and concluded that the IPMNmay be
influencing the pathogenesis of AIP [2]. Although they designated
their IPMN as branch duct type they were probably gastric type
since they were MUC2 negative, and MUC5AC positive. Tabata et al.
reported elevated serum IgG4 levels in 2/54 patients with IPMN
(4%), and found significant infiltration by IgG4 positive plasma cells
in 4/23 resected IPMN (17%) [4]. Vaquero et al. report two cases of
coincidental IPMN and AIP [5]. One patient, a 74-year-old woman,
exhibits several features of interest. (1) She was found to harbor a
CFTR gene mutation. (2) Her IPMN was classed as pancreatobiliary
type on the basis of mucin stains. (3) AIP involved her pancreas
diffusely.
Vaquero's second patient, a 79 year old male, is also of interest
because of these features: (1) The patient had an IPMN designated
as “branch duct type” resected 6 years earlier and the resected
specimen showed no stigmata of AIP and sparse IgG4 positive
plasma cells. (2) The IPMN associated with AIP was designated as
intestinal phenotype. (3) The AIP was type 1 with extrapancreatic
involvement and diffuse involvement of the pancreas. As noted
above, the authors conclude “common risk factors to IPMN and AIP
may facilitate its (sic) coincidental generation.” [5].
There are four major subtypes of IPMN: gastric type, intestinal
type, oncocytic, and pancreatobiliary. Our case and most coinci-
dental occurrences of IPMN and AIP have been with gastric type
IPMN, however, the cases reported by Vaquero et al. indicate that
other types of IPMNmay be involved [5]. To date we have found no
examples of IPMN associated with type 2 AIP.
The finding by Dhall et al. of varying numbers of IgG4-positive
plasma cells in the vicinity of pancreatic ductal adenocarcinomas
suggests that these carcinomas may also produce an epitope that
elicits an IgG4 response [6]. There are also reports of coincidental
occurrence of AIP and pancreatic ductal adenocarcinomas (PDAC)
[9e11], and a report of a patient with a mucinous cystic neoplasm
and stigmata of AIP [12]. The latter authors speculated that their
case reflected “an anti-inflammatory antitumor response driven by
Th2 cytokines” rather than a typical type 1 AIP (IgG4-related
disease).
The incidence of AIP in Japan is estimated to be 1/100,000[13,14]
and is predominately type 1. No such data are available for the US,
but we note that the fraction of AIP that is type 1 vs. type 2 is lower
in the US than in Japan [15]. Using insurance claims and SEER data,
Klibansky et al. estimated that the rate of all IPMN in 2005 (4.35 per
100,000 person years), was 68.5 fold higher than that of malignant
IPMN (0.06 per 100,000 person years) [16]. Although it has been
estimated that one third of IPMN are malignant [17], Klibansky
suggests that studies of surgical specimens tend to oversample
larger, symptomatic lesions and exaggerate the proportion of ma-
lignant lesions among all IPMN [16,18,19]. Even so, the incidence of
simultaneous AIP and IPMN,malignant or not, in a patient would be
extremely low if their occurrence were purely sporadic (the prod-
uct of independent probabilities). This seems at odds with the
growing number of reports of coincidental type 1 AIP and IPMN
(Table 2 plus our index case). The data reported here and by Tabata
et al. [4] suggest that the association of these diseases is more than
coincidental.
Overall, our data and that in the literature are consistent with
these conclusions: a small subset of IPMN, MCN and PDAC elicit an
IgG4 autoimmune response that may progress to peritumoral AIP,
and less often to diffuse AIP and other manifestations of IgG4-
related systemic disease. The data and literature also raise the
question: should peritumoral AIP be regarded as an established
subset of type 1 AIP that is characterized by the close association of
the AIP with a neoplasm?
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Table 2
Reports of simultaneous IPMN and AIP.
Author Year IPMN type AIP type
Naitoh 2013 gastric Type 1
Bateman 2013 Type 1 (2 cases)
Tabata 2013 Type 1
Urata 2013 Branch duct Type 1
Vaquero 2014 Pancreatobiliary (case 1) Type 1
Intestinal (case 2) Type 1
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